Nykode Therapeutics
NYKD.OL
#9031
Rank
C$0.12 B
Marketcap
$0.38
Share price
4.57%
Change (1 day)
-85.61%
Change (1 year)

Revenue for Nykode Therapeutics (NYKD.OL)

Revenue in 2024 (TTM): C$5.26 Million

According to Nykode Therapeutics's latest financial reports the company's current revenue (TTM ) is C$5.64 Million. In 2023 the company made a revenue of C$17.11 Million an increase over the revenue in the year 2022 that were of C$9.72 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Nykode Therapeutics from 2021 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) C$5.26 M-69.25%
2023 C$17.11 M75.94%
2022 C$9.72 M-77.53%
2021 C$43.28 M